tradingkey.logo
tradingkey.logo
Search

Brainsway Ltd

BWAY
Add to Watchlist
10.110USD
-0.140-1.37%
Close 11-13 16:00(ET)
406.96MMarket Cap
22.00P/E TTM

About Brainsway Ltd Company

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Brainsway Ltd Profile

Ticker SymbolBWAY
Company nameBrainsway Ltd
IPO dateDec 24, 2006
CEOLevy (Hadar)
Number of employees120
Security typeDepository Receipt
Fiscal year-endDec 24
Address16 Hartum Street Rad Tower, 14Th Floor
CityJERUSALEM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code9777516
Phone97225813140
Websitehttps://www.brainsway.com/
Ticker SymbolBWAY
IPO dateDec 24, 2006
CEOLevy (Hadar)

Company Executives of Brainsway Ltd

Name
Name/Position
Position
Shareholding
Change
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
1.38M
--
Mr. Avner Lushi
Mr. Avner Lushi
Independent Director
Independent Director
6.25K
--
Mr. Amiram (Ami) Boehm
Mr. Amiram (Ami) Boehm
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Aron Tendler, M.D.
Dr. Aron Tendler, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Menachem C. Klein, Esq.
Mr. Menachem C. Klein, Esq.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
--
--
Dr. Colleen A. Hanlon, Ph.D.
Dr. Colleen A. Hanlon, Ph.D.
Vice President - Medical Affairs
Vice President - Medical Affairs
--
--
Mr. Eric Hirt
Mr. Eric Hirt
Vice President of US Sales
Vice President of US Sales
--
--
Ms. Moria (Ankri) Ben Soussan
Ms. Moria (Ankri) Ben Soussan
Vice President - Research & Development
Vice President - Research & Development
--
--
Mr. Ido Marom
Mr. Ido Marom
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher Boyer
Mr. Christopher Boyer
Vice President - Global Marketing
Vice President - Global Marketing
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
1.38M
--
Mr. Avner Lushi
Mr. Avner Lushi
Independent Director
Independent Director
6.25K
--
Mr. Amiram (Ami) Boehm
Mr. Amiram (Ami) Boehm
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Aron Tendler, M.D.
Dr. Aron Tendler, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Menachem C. Klein, Esq.
Mr. Menachem C. Klein, Esq.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
--
--
Dr. Colleen A. Hanlon, Ph.D.
Dr. Colleen A. Hanlon, Ph.D.
Vice President - Medical Affairs
Vice President - Medical Affairs
--
--

FAQs

Who are the top five shareholders of Brainsway Ltd?

The top five shareholders of Brainsway Ltd are: Dr. David Zacut, M.D.

How many institutions hold shares of Brainsway Ltd (BWAY)?

As of 2026Q1, 95 institutions hold shares of Brainsway Ltd, with a combined market value of approximately 12.27M, accounting for 30.66% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -3188785.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.